Dr. Fantine Giap faced challenges in treating a young patient with a rare sarcoma due to insurance delays for proton therapy. New research shows high rates of approval on appeal post-denial. Dr. Fumiko Chino’s study found delays can have fatal consequences, especially with fast-growing cancers. Insurance denial affects patient care, causes stress, and burdens clinicians. Delays can impact outcomes and waste time and money. Efforts are being made to improve the system, including the proposed Improving Seniors’ Timely Access to Care Act. Changes are needed to support patients with rare cancers and ensure timely access to life-saving treatments.
Source link
How Prior Authorization Harms Care
